Virtus LifeSci Biotech Products ETF
17 hedge funds and large institutions have $9.77M invested in Virtus LifeSci Biotech Products ETF in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$463K | |
| 2 | +$245K | |
| 3 | +$229K | |
| 4 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
+$15K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$10.8K |
Top Sellers
| 1 | -$1.26M | |
| 2 | -$1.23M | |
| 3 | -$668K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$288K |
| 5 |
LPL Financial
San Diego,
California
|
-$75.1K |